Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris
P Preclinical data demonstrate ATR-01 delivers functional filaggrin, restoring skin barrier integrity and supporting advancement toward first-in-human studies BRANFORD, Conn., April 28, 2026 /PRNewswire/ — Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies…
Sevii Launches Autonomous Cyber Swarm Defense to Combat AI-Driven Threat Volume & Speed
B Sevii redefines cybersecurity economics, removing the need for AI token usage costs against emerging AI based attacks happening at machine scale & speed CHARLOTTE, N.C., April 28, 2026 /PRNewswire/ — Sevii, the leader in Autonomous Defense & Remediation (ADR),…
Life insurance explained: How to choose or reassess your coverage
B (BPT) – May 2 is National Life Insurance Day. For millions of Americans, now is the time to re-examine your current policy or think about applying for one. Even though most people think life insurance can be complicated, the…
PharmaLogic announces opening of new PET radiopharmaceutical manufacturing facility in Atlanta, Georgia
B ATLANTA, April 28, 2026 /PRNewswire/ — PharmaLogic Holdings Corp., (“PharmaLogic” or “the Company”), a leading contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, today announces the opening of its new PET radiopharmaceutical manufacturing facility in Atlanta, Georgia. The…
Genezen and The Charlotte & Gwenyth Gray Foundation to Cure Batten Disease Announce Manufacturing Partnership for CLN6 Gene Therapy Clinical Trial
P INDIANAPOLIS and LOS ANGELES, April 28, 2026 /PRNewswire/ — Genezen, a gene therapy contract development and manufacturing organization (CDMO), and The Charlotte & Gwenyth Gray Foundation to Cure Batten Disease today announced a manufacturing partnership to advance a CLN6…
Argo Biopharma Announces First Subject Dosed in Phase I Study of siRNA Therapeutic BW-50218
P SHANGHAI and NEW YORK, April 28, 2026 /PRNewswire/ — Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, today announced the first subject has been dosed in its Phase I clinical trial evaluating…
Rivermate Launches as a Unified Global Employer of Record Platform, Bringing Together Eos Global Expansion, Serviap Global, and Hightekers’ EOR Operations
B One global brand. 38 owned legal entities. Coverage in 180+ countries, serving companies and professionals wherever work happens. LONDON and DUBAI, UAE, April 28, 2026 /PRNewswire/ — Hightekers, Eos Global Expansion, Serviap Global, and Rivermate today announced the unification…
The Luxury Collection Debuts on Rhodes with the Opening of Amoh, a Luxury Collection Resort, Rhodes
B Set on a secluded peninsula near Lindos, the resort introduces a new chapter of refined island living in Greece’s Dodecanese archipelago. BETHESDA, Md., April 28, 2026 /PRNewswire/ — The Luxury Collection announces the opening of Amoh, a Luxury Collection Resort, Rhodes, marking…
Deloitte Private Survey: Private Companies Shift Digital and AI Investment from Exploration to Implementation
B Nearly two-thirds (64%) of private companies surveyed with $500 million or more in annual revenue have experienced moderate to significant ROI from AI investments NEW YORK, April 28, 2026 /PRNewswire/ — A new Deloitte Private survey found that revenue…
Trailhead Biosystems Expands iPSC Derived Cell Portfolio with TrailBio® Endothelial Cells
B iPSC-derived endothelial cells support vascular biology, drug discovery and toxicity studies BEACHWOOD, Ohio, April 28, 2026 /PRNewswire/ — Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing human cell innovation, announces the commercial launch of TrailBio® Endothelial Cells, a functionally…

